Genetic damage and the inhibition of 7,12-dimethylbenz[ a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice

• Published in: Cancer letters 1995-08, Vol.95 (1), p.125-133
• Main Authors: Giri, Ashok Kumar, Lu, Lee-Jane W.
• Format: Article
• Language: English
• Subjects: 9,10-Dimethyl-1,2-benzanthracene - antagonists & inhibitors; Animals; Biological and medical sciences; Breast cancer; Carcinogenesis, carcinogens and anticarcinogens; Cell replication; Daidzein; DNA adducts; DNA Adducts - chemistry; DNA damage; DNA Damage - drug effects; Female; Foods and miscellaneous; Genistein; Isoflavones - pharmacology; Medical sciences; Mice; Mice, Inbred ICR; Phytoestrogens; Prevention; Sister Chromatid Exchange - drug effects; Tumors
• ISSN: 0304-3835; 1872-7980
• DOI: 10.1016/0304-3835(95)03877-Y

Populations consuming soybeans have reduced rates of breast, colon and prostate cancer possibly due, in part, to the presence in soybeans of two estrogenic isoflavones, genistein and daidzein. This study investigated the genotoxicity of these soya isoflavones and their interactions with 7,12-dimethylbenz[ a]anthracene (DMBA)-induced sister chromatid exchanges (SCE) in bone marrow cells and DNA adduct formations in liver and mammary glands of mice. Groups of female ICR mice were pretreated i.p. with daidzein and/or genistein (10–20 mg/kg per day for 6 days or 50 mg/kg per 12 h for 3 days) or with the solvent, dimethylsulfoxide (DMSO). The mice were implanted with bromodeoxyuridine (BrdU) tablets s.c., and treated with DMBA (50 mg/kg) i.p. and colchicine (4 mg/kg) i.p. 24, 23, and 2 h before sacrifice, respectively. In bone marrow cells, DMBA alone induced 11.73 ± 1.42 SCE/cell compared to 4.35 ± 0.83 SCE/cell in the DMSO treated controls ( P = 0.001). DMBA induced 20% fewer SCE ( P < 0.05) in mice pretreated with daidzein, genistein or a combination of genistein and daidzein (6 × 20 mg/kg per day for 6 days) when compared to mice that received no pretreatments. Genistein at 50 mg/kg per 12 h for 3 days also inhibited DMBA-induced SCE by 20%. However, treatment for 3 days with 50 mg/kg per 12 h of genistein or daidzein alone, or a combination of daidzein plus genistein (without DMBA treatment) also induced more SCE than treatment with only the solvent (DMSO, P < 0.05). Pretreatment with both the low and the high doses of daidzein plus genistein or the high dose of genistein reduced the replication index of bone marrow cells when compared to pretreatment with DMSO ( P < 0.05). Pretreatment with genistein reduced DMBA-induced DNA adduct formation by 34%, but this was only marginally significant ( P = 0.08) due to the large inter-individual variability in adduct levels. These results show that genistein and daidzein suppress SCE and possibly DNA adduct formation induced by the known carcinogen, DMBA. This response to a low dose isoflavone exposure may be partly responsible for the protective effect against endocrine cancers of soya consumption.